Catalyst Wire Dossier Catalyst Wire Dossier

Ultra-Fast CD19 CAR-T Therapy

CD19-targeted CAR-T cell therapy · Chongqing Precision Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ultra-Fast CD19 CAR-T Therapy, covering 2025-11-18 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE [Phase 1]

See pricing